PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
66 hedge funds and large institutions have $178M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $191M → $178M (-$12.3M)
Holders
66
Holding in Top 10
–
Calls
$24K
Puts
$13K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$1.6M | |
| 3 | +$775K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$663K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$577K |
Top Sellers
| 1 | -$5.74M | |
| 2 | -$5.51M | |
| 3 | -$2.2M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.11M |
| 5 |
MA
MCF Advisors
Covington,
Kentucky
|
-$482K |